Vericel Corp. (VCEL)
35.96
+1.99
(+5.86%)
USD |
NASDAQ |
Feb 13, 16:00
35.95
-0.01
(-0.03%)
Pre-Market: 20:00
Vericel Market Cap : 1.819B for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 23.84M |
| ADMA Biologics, Inc. | 3.829B |
| Veracyte, Inc. | 2.828B |
| ACADIA Pharmaceuticals, Inc. | 3.727B |
| Agenus, Inc. | 105.53M |
Market Cap Related Metrics
| PE Ratio | 149.34 |
| PS Ratio | 7.102 |
| PEG Ratio | 0.5223 |
| Price to Book Value | 5.650 |
| Price to Free Cash Flow | 90.18 |
| Price | 35.96 |
| Earnings Yield | 0.67% |
| PEGY Ratio | 0.5223 |
| Operating PE Ratio | 258.51 |
| Normalized PE Ratio | 149.34 |